Charlie Wright

OverviewAI-generated summary

Charlie Wright's research interests lie in the intersection of molecular biology and health sciences. Their recent work includes an investigation into the dysregulation of AKT signaling in osteosarcoma, specifically how it reprograms the cancer cells to rely on EP300. Wright has also contributed to the understanding of neuroblastoma by performing a meta-analysis of single-cell RNA-seq datasets, identifying conserved and divergent gene expression programs across human and preclinical models. Another publication addresses the critical role of medication reconciliation for patients with Parkinson's disease. These studies highlight a focus on understanding disease mechanisms at a molecular level and improving patient care through evidence-based practices.

Metrics

• Publications: 3